Parmax Pharma P/B Ratio
Parmax Pharma (PARMAX) P/B ratio is -5.61 (Low), book value per share ₹-15.00 vs Healthcare average P/B of -0.17 — Very Low - Significant discount to book value, potential distress or value opportunity. View PARMAX 52-week performance for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PARMAX P/B Ratio — Valuation Insights & Book Value Analysis
Parmax Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B -5.61 (Low). Review Parmax Pharma P/E valuation to evaluate earnings-based valuation against sector peers.
- Stock appears undervalued with PB of -5.61, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 288.9% below historical average
- Trading at discount to sector average PB of -0.17
Parmax Pharma P/B Ratio Historical Trend
PARMAX annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see PARMAX screener.
PARMAX Historical P/B Ratio — Book Value Per Share & Year-End Price
Parmax Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2023 | 2.71 | ₹12.0 | ₹32.57 | ₹6 | Moderate |
| 2022 | 3.23 | ₹12.0 | ₹38.70 | ₹6 | High |
PARMAX vs Healthcare Peers — P/B Ratio Comparison
Parmax Pharma P/B -5.61 vs Healthcare average -0.17, median 0.6 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |